Scientists test new Drug's brain impact using ketamine
NCT ID NCT05049343
Summary
This study aimed to understand how an experimental drug called SAGE-904 affects brain activity. Researchers gave 22 healthy volunteers either SAGE-904 or a placebo, then measured their brain waves before and after receiving a low dose of ketamine. The goal was to see if SAGE-904 engages its intended target in the brain, which could inform future research for brain disorders.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sage Investigational Site
Newark, New Jersey, 07103, United States
Conditions
Explore the condition pages connected to this study.